Concepedia
Statistics
Publications
5
Citations
119
H-Index
Active since
2002
Affiliations
Roche (Switzerland)(Current)
Board of the Swiss Federal Institutes of Technology
ETH Zurich
S. Sahli is an author at Roche (Switzerland) specializing in medicinal chemistry, pharmacology, and pharmacy.
Publications per year
2002–2020
Second‐Generation Inhibitors for the Metalloprotease Neprilysin Based on Bicyclic Heteroaromatic Scaffolds: Synthesis, Biological Activity, and X‐Ray Crystal‐Structure Analysis
S. Sahli, B. Frank, W. Bernd Schweizer et al. · Helvetica Chimica Acta · 2005 · 32 citations
Pharmacy, Medicinal Chemistry, Pharmacology +15
A New Class of Inhibitors for the Metalloprotease Neprilysin Based on a Central Imidazole Scaffold
S. Sahli, Bernhard Stump, Tobias Welti et al. · Helvetica Chimica Acta · 2005 · 32 citations · Full text
Pharmacy, Medicinal Chemistry, Pharmacology +14
Structure-Based Design of Nonpeptidic Thrombin Inhibitors: Exploring the D-Pocket and the Oxyanion Hole
P. Betschmann, S. Sahli, François Diederich et al. · Helvetica Chimica Acta · 2002 · 26 citations
Pharmacy, Medicinal Chemistry, Pharmacology +16
Structure‐Based Design, Synthesis, and in vitro Evaluation of Nonpeptidic Neprilysin Inhibitors
S. Sahli, Bernhard Stump, Tobias Welti et al. · ChemBioChem · 2004 · 19 citations
Synthesis of Vixotrigine, a Voltage- and Use-Dependent Sodium Channel Blocker. Part 2: Development of a Late-Stage Process
Robbie Chen, Vincent Couming, John P. Guzowski et al. · Organic Process Research & Development · 2020 · 10 citations
Pharmacy, Medicinal Chemistry, Pharmacology +13
1–5 of 5